Description

HCQS 200 (HYDROXYCHLOROQUINE TABLET)

Hydroxychloroquine (HCQS 200 tablets) are prescribed medicine that was approved many years back to treat primarily Malaria. It’s also used to treat autoimmune diseases like Rheumatoid Arthritis and Lupus. Hydroxychloroquine is also popular by its brand name – Plaquenil that is closely related to chloroquine (again used for the treatment of Malaria). HCQS 200 is approved for Malaria, Lupus and Rheumatoid Arthritis.

Hydroxychloroquine HCQS 200 mg / 400 mg tablets produced by Ipca Laboratories and are used to treat and supress Malaria, Rheumatoid Arthritis and Systemic Lupus Erythematosus. The tablets are not recommended for patients with an eye disease. Blood glucose levels and Muscle function should be closely monitored while taking HCQS 200.

The unique benefits of HCQS 200 (hydroxychloroquine tablet)

HCQS 200 (hydroxychloroquine tablet) prevents and relieves the symptoms of this disease, including joint pain, edema, and stiffness.
HCQS 200

• It can also help delay joint deterioration, minimize disability, and keep you functioning for as long as feasible.
• The medicine’s impact may take many weeks or even months to become apparent.
• Because the medicine is available as a tablet, So no need for needles.
• Extremely powerful
• Simple dosage
• Low-cost solution
• This HCQS 200 (hydroxychloroquine tablet) medicine does not have any significant adverse effects and serious side effects.

HCQS 200 (hydroxychloroquine tablet) action mechanism

• Hydroxychloroquine is just a 4-aminoquinoline antimalarial that works similarly to chloroquine but is mostly used to treat SLE and rheumatoid arthritis.
• It disrupts the normal operation of sensitive malarial parasites’ digestive vacuoles by raising pH and interfering with lysosomal Hb breakdown.
• Rheumatic disease: It may take 4-6 weeks to see a response.
• Oral absorption is quick and efficient.

HCQS 200 (hydroxychloroquine tablet) Usage Instructions

• Oral use of HCQS 200 (hydroxychloroquine tablet) is advised.
• Swallow the hydroxychloroquine tablet pill whole with water.
• The pill must not be crushed, chewed, or broken.
• Do not stop taking your prescription or skip doses without consulting your doctor.
• Do not exceed the recommended amount of dosage.
• The dose and timeframe should be taken exactly as suggested by your doctor.
• It is advisable to take this medication at a predetermined time.
• It is critical not to exceed the prescribed dosage of this medication.
• Swallow the tab with water right once the pill is taken out of the strip
• It is not encouraged to consume two doses of this drug at the same time since this might be harmful to your health.
• Keep in mind that the drug takes a few weeks to work, so you should take it regularly even if you think it isn’t helping you.
• You must continue to take the medication unless your doctor tells you otherwise.
• It may take up to several weeks to observe the medicine’s impact.
• Only the individual for whom a certified physician has prescribed hydroxychloroquine tablet should take it.

Side Effects and Adverse Reactions

The majority of people who use HCQS 200 (hydroxychloroquine tablet) do not experience any serious adverse effects. The following adverse effects with the use of this medication may not even appear. The following are some of the side effects:

• Allergic responses to the hydroxychloroquine tablet.
• Vision Blurred.
• Enhanced light sensitivity.

When hydroxychloroquine tablet is used according to the recommended instructions, Tab is typically well-tolerated. The majority of adverse effects are generally moderate and disappear on their own. However, if they appear to last longer, please visit your physician.

Hydroxychloroquine HCQS 200 mg and 400 mg tablets are available at Gandhi Medicos.

Hydroxychloroquine tablet is also available in these countries: (South East Asia, South America, Eastern Europe, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Macedonia, Poland, Republic of Kosovo, Republic of Moldova, Romania, Russia, Serbia, Slovak Republic, Slovenia, Malaysia, Indonesia, Philippines, Venezuela and Korea.) and many more…